Correlation Between Morgan Stanley and CanSino Biologics

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and CanSino Biologics, you can compare the effects of market volatilities on Morgan Stanley and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and CanSino Biologics.

Diversification Opportunities for Morgan Stanley and CanSino Biologics

0.58

Correlation Coefficient

Morgan Stanley  CanSino Biologics

Very weak diversification

The 3 months correlation between Morgan and CanSino is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and CanSino Biologics go up and down completely randomly.

Pair Corralation between Morgan Stanley and CanSino Biologics

Given the investment horizon of 90 days Morgan Stanley is expected to generate 4.05 times less return on investment than CanSino Biologics. But when comparing it to its historical volatility, Morgan Stanley Direct is 4.51 times less risky than CanSino Biologics. It trades about 0.08 of its potential returns per unit of risk. CanSino Biologics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  296.00  in CanSino Biologics on October 12, 2024 and sell it today you would earn a total of  44.00  from holding CanSino Biologics or generate 14.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	96.72%
Values	Daily Returns

Morgan Stanley Direct  vs.  CanSino Biologics

Morgan Stanley Direct

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent fundamental indicators, Morgan Stanley is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

CanSino Biologics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, CanSino Biologics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Morgan Stanley and CanSino Biologics

The main advantage of trading using opposite Morgan Stanley and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.

The idea behind Morgan Stanley Direct and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.